File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Book Chapter: In the Pipeline: Emerging Therapy for Classical Ph-Negative MPNs

TitleIn the Pipeline: Emerging Therapy for Classical Ph-Negative MPNs
Authors
Gill, HarinderYung, Yammy
Issue Date28-Sep-2023
PublisherSpringer Nature Singapore
Abstract

Conventional therapy for myeloproliferative neoplasm (MPN) has modest disease-modifying effect. In this chapter, we discuss the emerging novel agents and approaches that may potentially modify the underlying disease biology in MPN.


Persistent Identifierhttp://hdl.handle.net/10722/341856
ISBN
9789819938094

 

DC FieldValueLanguage
dc.contributor.authorGill, Harinder-
dc.contributor.authorYung, Yammy -
dc.date.accessioned2024-03-26T05:37:43Z-
dc.date.available2024-03-26T05:37:43Z-
dc.date.issued2023-09-28-
dc.identifier.isbn9789819938094-
dc.identifier.urihttp://hdl.handle.net/10722/341856-
dc.description.abstract<p>Conventional therapy for myeloproliferative neoplasm (MPN) has modest disease-modifying effect. In this chapter, we discuss the emerging novel agents and approaches that may potentially modify the underlying disease biology in MPN.<br></p>-
dc.languageeng-
dc.publisherSpringer Nature Singapore-
dc.relation.ispartofPathogenesis and Treatment of Leukemia-
dc.titleIn the Pipeline: Emerging Therapy for Classical Ph-Negative MPNs-
dc.typeBook_Chapter-
dc.identifier.doi10.1007/978-981-99-3810-0_47-
dc.identifier.eisbn9789819938100-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats